NCT07025811

A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

← Hub

Registry fields

Overall status: COMPLETED
Conditions: Dry Eye Disease
Study type: INTERVENTIONAL
Phase: PHASE4
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: Vevye®, Xiidra®
Lead sponsor: Hoffmann-La Roche (INDUSTRY)

Cached at: 2026-07-28 02:39:07

View on ClinicalTrials.gov

Brief summary

This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report